Results 121 to 130 of about 2,567 (167)

A novel regulatory axis of MSI2-AGO2/miR-30a-3p-CGRRF1 drives cancer chemoresistance by upregulating the KRAS/ERK pathway. [PDF]

Neoplasia
Lu R, Zhang Y, Chen R, Li L, Huang C, Zhou Z, Cao Y, Li H, Li J, Zhang Y, Wang Y, Huang J, Zhao X, Feng J, Yu J, Du C.   +15 more
europepmc   +1 more source

RNA Binding Proteins as Potential Therapeutic Targets in Colorectal Cancer. [PDF]

Cancers (Basel)
Singh V, Singh A, Liu AJ, Fuchs SY, Sharma AK, Spiegelman VS.   +5 more
europepmc   +1 more source

Metabolomic profiling of patients with lupus nephritis reveals unique metabolites that are modulated through type I interferon inhibition by anifrolumab treatment in a phase 2 trial. [PDF]

RMD Open
Gavin PG, Allman EL, Jayne D, Mysler E, Amoura Z, Di Poto C, Tian X, Hess S, Csomor E, Brohawn PZ, Muthas D, Platt A, Anzillotti C, Stone H, Seth A, Woollard K, Al-Mossawi H, Lindholm C, Ferrari N.   +18 more
europepmc   +1 more source

The Impact of Polycomb Group Proteins on 3D Chromatin Structure and Environmental Stresses in Plants. [PDF]

Plants (Basel)
Liu Y, Xiao S, Yang M, Guo G, Zhou Y.
europepmc   +1 more source

Correction: Circ_0055625 knockdown inhibits tumorigenesis and improves radiosensitivity by regulating miR-338-3p/MSI1 axis in colon cancer. [PDF]

World J Surg Oncol
Gao C, Zhang Y, Tian Y, Han C, Wang L, Ding B, Tian H, Zhou C, Ju Y, Peng A, Yu Q.   +10 more
europepmc   +1 more source

Unique transcriptomes of sensory and non-sensory neurons: insights from Splicing Regulatory States. [PDF]

Mol Syst Biol
Ciampi L, Serrano L, Irimia M.
europepmc   +1 more source

Neuroprotective properties of erythropoietin (Epo) and its receptor (EpoR) in open spinal dysraphism (OSD): an investigation of EpoR expression in a rat OSD model, along with in vitro studies on the neuroprotective effects of Epo on rat spinal cord-derived neural progenitor cells. [PDF]

Childs Nerv Syst
Knerlich-Lukoschus F, Clüver J, Manczuk I, Bayler F, Hellmold D, Synowitz M, Held-Feindt J.   +6 more
europepmc   +1 more source

RNA binding proteins in cancer chemotherapeutic drug resistance. [PDF]

Front Cell Dev Biol
Vembuli H, Gor R, Ramalingam S, Perales S, Rajasingh J.   +4 more
europepmc   +1 more source

Pyriproxyfen, villain or good guy? A brief review. [PDF]

Arch Endocrinol Metab
Cabral AP, Maia FPDS, Magliano DC, Graceli JB, Soares P, Morris EAR, Miranda-Alves L.   +6 more
europepmc   +1 more source